These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16671339)

  • 1. Collagen metabolism in extracellular matrix may be involved in arterial stiffness in older hypertensive patients with left ventricular hypertrophy.
    Ishikawa J; Kario K; Matsui Y; Shibasaki S; Morinari M; Kaneda R; Hoshide S; Eguchi K; Hojo Y; Shimada K
    Hypertens Res; 2005 Dec; 28(12):995-1001. PubMed ID: 16671339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen type-I degradation is related to arterial stiffness in hypertensive and normotensive subjects.
    McNulty M; Mahmud A; Spiers P; Feely J
    J Hum Hypertens; 2006 Nov; 20(11):867-73. PubMed ID: 16598292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of benidipine hydrochloride on severe left ventricular hypertrophy and collagen metabolism in patients with essential hypertension.
    Hirono O; Fatema K; Nitobe J; Takeishi Y; Kaneko K; Shiga R; Kubota I
    J Cardiol; 2002 Apr; 39(4):195-204. PubMed ID: 11977767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
    Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z
    Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrocardiographic left ventricular hypertrophy and arterial stiffness: the Ohasama study.
    Watabe D; Hashimoto J; Hatanaka R; Hanazawa T; Ohba H; Ohkubo T; Kikuya M; Totsune K; Imai Y
    Am J Hypertens; 2006 Dec; 19(12):1199-205. PubMed ID: 17161763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between markers of collagen turnover, arterial stiffness and left ventricular hypertrophy in chronic kidney disease (CKD): the Renal Research Institute (RRI)-CKD study.
    Dellegrottaglie S; Sands RL; Gillespie BW; Gnanasekaran G; Zannad F; Sengstock D; Finkelstein F; Kiser M; Eisele G; Hinderliter AL; Levin NW; Cattan V; Saran R; Rajagopalan S
    Nephrol Dial Transplant; 2011 Sep; 26(9):2891-8. PubMed ID: 21562144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced radial late systolic pressure augmentation in hypertensive patients with left ventricular hypertrophy.
    Hashimoto J; Watabe D; Hatanaka R; Hanasawa T; Metoki H; Asayama K; Ohkubo T; Totsune K; Imai Y
    Am J Hypertens; 2006 Jan; 19(1):27-32. PubMed ID: 16461187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.
    Tsai WC; Lin CC; Chen JY; Huang YY; Lee CH; Li WT; Weng CM; Chen JH
    Blood Press; 2008; 17(4):233-8. PubMed ID: 18671144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between brachial-ankle pulse wave velocity and arterial compliance and cardiovascular risk factors in elderly patients with arteriosclerosis.
    Li B; Gao H; Li X; Liu Y; Wang M
    Hypertens Res; 2006 May; 29(5):309-14. PubMed ID: 16832150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of pulse wave velocity on coronary flow reserve in patients with essential hypertension].
    Wang GH; Hu DY
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):54-7. PubMed ID: 15808080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
    Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
    Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher brachial-ankle pulse wave velocity is associated with more advanced carotid atherosclerosis in end-stage renal disease.
    Munakata M; Sakuraba J; Tayama J; Furuta T; Yusa A; Nunokawa T; Yoshinaga K; Toyota T
    Hypertens Res; 2005 Jan; 28(1):9-14. PubMed ID: 15969249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between wasted pressure effort and left ventricular hypertrophy in hypertension: influence of arterial wave reflection.
    Hashimoto J; Nichols WW; O'Rourke MF; Imai Y
    Am J Hypertens; 2008 Mar; 21(3):329-33. PubMed ID: 18202668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients.
    Xu Y; Wu Y; Li J; Ma W; Guo X; Luo Y; Hu D
    Hypertens Res; 2008 Jun; 31(6):1079-85. PubMed ID: 18716354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer.
    Ylisirniö S; Höyhtyä M; Mäkitaro R; Pääakkö P; Risteli J; Kinnula VL; Turpeenniemi-Hujanen T; Jukkola A
    Clin Cancer Res; 2001 Jun; 7(6):1633-7. PubMed ID: 11410500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the angiotensin receptor blocker candesartan on arterial stiffness and markers of extracellular matrix metabolism in patients with essential hypertension.
    Sasamura H; Kitamura Y; Nakamura M; Ryuzaki M; Saruta T
    Clin Exp Hypertens; 2006 Jul; 28(5):511-20. PubMed ID: 16820347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of increased arterial stiffness and inflammation with proteinuria and left ventricular hypertrophy in non-diabetic hypertensive patients.
    Tsai WC; Lin CC; Huang YY; Chen JY; Chen JH
    Blood Press; 2007; 16(4):270-5. PubMed ID: 17852088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective angiotensin receptor antagonism with valsartan decreases arterial stiffness independently of blood pressure lowering in hypertensive patients.
    Nakamura T; Fujii S; Hoshino J; Saito Y; Mizuno H; Saito Y; Kurabayashi M
    Hypertens Res; 2005 Dec; 28(12):937-43. PubMed ID: 16671331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and cardiorespiratory fitness are associated with arterial stiffening and left ventricular remodelling.
    Gando Y; Kawano H; Yamamoto K; Sanada K; Tanimoto M; Oh T; Ohmori Y; Miyatani M; Usui C; Takahashi E; Tabata I; Higuchi M; Miyachi M
    J Hum Hypertens; 2010 Mar; 24(3):197-206. PubMed ID: 19609287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Tayebjee MH; Nadar S; Blann AD; Gareth Beevers D; MacFadyen RJ; Lip GY
    Am J Hypertens; 2004 Sep; 17(9):764-9. PubMed ID: 15363817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.